A clinical trial to compare the efect of a drug called lognocaine in its local and intravenous form for insertion of a tube that passes down the throat(laryngeal mask airway)
Not Applicable
- Conditions
- Health Condition 1: L024- Cutaneous abscess, furuncle and carbuncle of limbHealth Condition 2: L00-L99- Diseases of the skin and subcutaneous tissueHealth Condition 3: L05- Pilonidal cyst and sinusHealth Condition 4: O00-O9A- Pregnancy, childbirth and the puerperium
- Registration Number
- CTRI/2020/07/026636
- Lead Sponsor
- Dr Catharine Anto
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.consenting adults aged 20 to 50 years for whom LMA is the airway of choice.
2.adults belonging to either sex with ASA grade 1 or 2
Exclusion Criteria
1.patients with ASA grade 3 or more
2.pregnant women
3.obese patients (BMI more than 30)
4.patients with risk of aspiration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ease of insertion of laryngeal mask airwayTimepoint: At the time of insertion of laryngeal mask airway
- Secondary Outcome Measures
Name Time Method Hemodynamic responses following LMA insertionTimepoint: ECG, systolic blood pressure, diastolic blood pressure, mean arterial pressure, pulse oximetry ,capnography will be recorded at 1 minute interval for the first 5 minutes and thereafter at 5 minutes interval